Like LKM-1, LC-1 antibodies are considered bona fide diagnostic markers for AIH-2, whereas LKM-3 have only a minor significance in AIH diagnosis, since they have also been detected in a fraction of patients with hepatitis D (62, 63) and have only a low sensitivity (3, 53). Here, DNAL1 is linked to autoimmune hepatitis.